Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers

Summary

The study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of repeat ascending doses of GSK2018682. The study will also provide further evidence of the potential therapeutic dose-range by measuring the inhibitory effect of GSK2018682 on Absolute Lymphocyte Counts (ALC).

Timeline

Start

2010-10-10

Primary completion

2011-03-29

Completion

2011-03-29

Drugs

Indications